How many insider trades does FilingIQ track for TLSA?

FilingIQ tracks 8 Form 4 insider transactions for TLSA (Tiziana Life Sciences Ltd), covering filings from Jun 17, 2026 onwards. 4 of those are dated within the last 90 days.

Are TLSA insiders net buyers or net sellers?

Across the full Form 4 history for TLSA, 5 transactions (63%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TLSA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

What sector is TLSA in?

Tiziana Life Sciences Ltd (TLSA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $162.89M.

TLSA insider trading

NasdaqCM Healthcare

Tiziana Life Sciences Ltd: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

63% / 0%

Market cap

$162.89M

About Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.

Company website: www.tizianalifesciences.com

TLSA insider activity at a glance

FilingIQ tracks 8 insider transactions for TLSA in filings since Jun 17, 2026. The most recent transaction is dated Aug 15, 2026.

Across the full history, 5 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

View live TLSA trades on FilingIQ Raw filings on SEC EDGAR

Latest TLSA Form 4 filings

Elrifi Ivor Chief Executive Officer

Elrifi Ivor Chief Executive Officer

P Aug 6, 2026

Elrifi Ivor Chief Executive Officer

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Other Healthcare tickers with recent insider activity

UTHR 865

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

ATTO 123

Attovia Therapeutics, Inc.

TEM 104

Tempus AI, Inc.

CORT 103

CORCEPT THERAPEUTICS INC

CSTL 100

CASTLE BIOSCIENCES INC

Frequently asked

How many insider trades does FilingIQ track for TLSA?: FilingIQ tracks 8 Form 4 insider transactions for TLSA (Tiziana Life Sciences Ltd), covering filings from Jun 17, 2026 onwards. 4 of those are dated within the last 90 days.
Are TLSA insiders net buyers or net sellers?: Across the full Form 4 history for TLSA, 5 transactions (63%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TLSA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
What sector is TLSA in?: Tiziana Life Sciences Ltd (TLSA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $162.89M.

Methodology & sources

Every TLSA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.